At the molecular level, reactive carbonyl groups can react with amino groups on proteins, producing covalent links between biomolecules. Because these links connect neighboring molecular structures, they can create a more stable network rather than a collection of independent molecules. This chemistry provides a mechanistic basis for examining how matrix organization changes in biological systems.
Unlike enzyme-dependent crosslinking, this approach relies on chemical reactivity between available groups or on an added chemical crosslinker. In biomaterials, the crosslinker connects adjacent polymer chains; in biological systems, carbonyl and amino groups can participate. This distinction lets researchers investigate matrix-like structures without assigning the bond-forming step to an enzyme.
Defined reaction conditions influence how effectively adjacent molecules or polymer chains become linked and, therefore, the organization of the resulting material. In cancer research, that organization matters because extracellular-matrix structure and tissue stiffness are examined as variables affecting tumor-cell adhesion, migration, invasion, and response to therapy.
A basic workflow begins by selecting biomolecules or polymer chains that contain reactive groups or can be connected by a chemical crosslinker. The components are brought together under defined conditions, allowing covalent connections to form. The resulting structure can then serve as a controlled model of tissue organization.
It can be used to build disease models and biomaterials that reproduce selected biochemical and mechanical features of tumor tissues. By varying the resulting matrix organization or stiffness, researchers can examine consequences for tumor-cell adhesion, migration, invasion, and therapy response. These models connect material design with cancer-related cell behavior.
Results should be considered in relation to both biochemical organization and mechanical stiffness, rather than as effects of crosslinking alone. A model that more closely reproduces tumor-tissue features can help relate matrix conditions to changes in adhesion, migration, invasion, or therapy response. This framing supports comparisons among disease models and biomaterial designs.